Skip to content
Home/Companies/Biotech/Curadis

Curadis

Biotech·Germany·Active·10yr hold
Entry
2016
Hold
10yr
Status
Active

Who owns Curadis?

Curadis is currently owned by Sobera Capital through S-Refit AG (2016 vintage), since 2016.

Hand-verified · updated 2026-08-10

Sobera Capital
Investor
Sobera Capital
S-Refit AG · 2016 · Secondaries

Key facts

HQGermany
SectorBiotech
StatusActive

More from S-Refit AG

Other portfolio companies in the same fund.

Amicra
Exited 2018
Deep TechGermany· 2016
to
BioMAX
Exited 2022
HealthTechGermany· 2016
EnOcean
EnOcean
Exited 2024
Deep TechGermany· 2016
ERS electronic
Exited 2023
IndustrialsGermany· 2016
to
Isarna
Isarna
Active
BiotechGermany· 2016
knowis
knowis
Active
SoftwareGermany· 2016

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Antiverse
Antiverse
Active
Future Planet CapitalUK
CellCentric
CellCentric
Active
Future Planet CapitalUK
Crescendo Biologics
Crescendo Biologics
Active
Future Planet CapitalUK
Cytox Group
Exited 2024
Future Planet CapitalUK
GenSight Biologics
GenSight Biologics
Active
Sofinnova PartnersFrance
Healx
Healx
Active
Amadeus Capital PartnersUK
Track Curadis

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Curadis.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue